Releases › HCPCS Level II April 2026

HCPCS Level II April 2026

Effective 2026-04-01 to 2026-06-30. 9,068 codes in the release.

62added
7revised
6removed

Codes added 62

CodeDescription
A2040 Microlyte painguard, per square centimeter
A2041 Foundation drs+ duo, per square centimeter
A2042 Foundation drs+ solo, per square centimeter
A2043 Biobrane, per square centimeter
A2044 Biobrane glove, each
A2045 Novashield or novogen wound matrix, per square centimeter
A4318 Female external urinary collection cup, with or without ring attachment, per day
A4479 Electronic transanal irrigation system, includes electronic pump, water reservoir, tubing, and accessories, without catheter, any type
A6548 Accessory to custom gradient compression garment, silicone band, any size
A8005 Powered, cable driven grip assist glove, hand, finger, includes microprocessor, pressure sensors, all components and accessories, custom fitted
A8006 Powered, cable driven grip assist glove, hand, finger, includes pressure sensors, glove replacement only
A9294 Prescription digital cognitive and/or behavioral therapy, biofeedback, fda cleared, per course of treatment
C1743 Scaffold, endovascular non-coronary, resorbable drug eluting, with delivery system (implantable)
C8007 Open implantation of hypoglossal nerve neurostimulator array and pulse generator, not requiring insertion of a separate distal respiratory sensor electrode or electrode array
C8008 Revision or replacement of hypoglossal nerve neurostimulator array including connection to existing pulse generator
C8009 Removal of hypoglossal nerve neurostimulator array and pulse generator
C8010 Percutaneous placement of permanent common carotid embolic protection device, including all system components and imaging guidance; bilateral
C8011 Open implantation of hypoglossal nerve(s) neurostimulator electrode array(s) and receiver, including external power source and all system components
C8012 Revision or replacement of hypoglossal nerve(s) neurostimulator electrode array(s) and receiver
C8013 Removal of hypoglossal nerve(s) neurostimulator electrode array(s) and receiver
C9309 Injection, onasemnogene abeparvovec-brve, per treatment
C9818 Suzetrigine, oral, 1 mg
G0680 Detection and quantification of coronary artery calcium and/or aortic valve calcification from algorithmic analysis of computed tomography of the chest with report
G0681 Application of a premarket approval (pma), 510(k), 361 human cells, tissues or cellular and tissue-based products (hct/p) non-sheet form skin substitute for a wound surface area up to 100 sq cm; first 25 sq cm or less of wound surface area
G0682 Application of a premarket approval (pma), 510(k), 361 human cells, tissues or cellular and tissue-based products (hct/p) non-sheet form skin substitute for a wound surface area up to 100 sq cm; each additional 25 sq cm wound surface area, or part thereof (list separately in addition to code for primary procedure)
G0683 Application of a premarket approval (pma), 510(k), 361 human cells, tissues or cellular and tissue-based products (hct/p) non-sheet form skin substitute graft for a wound surface greater than or equal to 100 sq cm; first 100 sq cm wound surface area, or 1% of body area of infants and children
G0684 Application of a premarket approval (pma), 510(k), 361 human cells, tissues or cellular and tissue-based products (hct/p) non-sheet form skin substitute graft for a wound surface greater than or equal to 100 sq cm; each additional 100 sq cm wound surface area or part thereof, or each additional 1% of body area of infants and children, or part thereof (list separately in addition to code for primary procedure)
J0463 Injection, atropine sulfate (fresenius and therapeutically equivalent), 0.01 mg
J1098 Articaine ophthalmic, 8% solution, 0.4 ml
J1164 Injection, diltiazem hydrochloride in 0.72% sodium chloride, 0.5 mg
J1553 Injection, immune globulin (yimmugo), 100 mg
J3404 Injection, zopapogene imadenovec-drba suspension, per therapeutic dose
J8502 Injection, aprepitant (aponvie), 1 mg
J9003 Leuprolide injectable (camcevi etm), 1 mg
J9183 Gemcitabine intravesical system, 225 mg
J9277 Injection, pembrolizumab, 1 mg and berahyaluronidase alfa-pmph
J9278 Injection, carboplatin (avyxa), 1 mg
J9601 Injection, linvoseltamab-gcpt, 1 mg
L2221 Addition to lower extremity orthosis, ankle system, microprocessor-controlled feature plantarflexion and/or dorsiflexion, includes power source
L5992 All lower extremity prosthesis, foot shell for modular foot/non-solid ankle cushion heel (sach) replacement only
M0233 Intravenous infusion, tocilizumab-aazg, for hospitalized adult patients with covid-19 who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ecmo) only, includes infusion and post administration monitoring, first dose
M0234 Intravenous infusion, tocilizumab-aazg, for hospitalized adult patients with covid-19 who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ecmo) only, includes infusion and post administration monitoring, second dose
Q0238 Injection, tocilizumab-aazg, for hospitalized adult patients with covid-19 who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ecmo) only, 1 mg
Q4418 Biolab membrane wrap flow, per square centimeter (add-on, list separately in addition to primary procedure)
Q4419 Biolab membrane wrap lite flow, per square centimeter (add-on, list separately in addition to primary procedure)
Q4421 Biolab membrane wrap solo, per square centimeter (add-on, list separately in addition to primary procedure)
Q4422 A/c wrap, per square centimeter (add-on, list separately in addition to primary procedure)
Q4423 Biolab tri-membrane wrap flow, per square centimeter (add-on, list separately in addition to primary procedure)
Q4424 Revive ft, per square centimeter (add-on, list separately in addition to primary procedure)
Q4425 Revive tl, per square centimeter (add-on, list separately in addition to primary procedure)
Q4426 Dermabind tl + or dermabind tl x, per square centimeter (add-on, list separately in addition to primary procedure)
Q4427 Dermabind dl n or dermabind dl + or dermabind dl x, per square centimeter (add-on, list separately in addition to primary procedure)
Q4428 Dermabind sl n or dermabind sl + or dermabind sl x, per square centimeter (add-on, list separately in addition to primary procedure)
Q4429 Dermabind ch n or dermabind ch x, per square centimeter (add-on, list separately in addition to primary procedure)
Q4435 Renati membrane, per square centimeter (add-on, list separately in addition to primary procedure)
Q4436 Renati ac membrane, per square centimeter (add-on, list separately in addition to primary procedure)
Q4437 Revival ac, per square centimeter (add-on, list separately in addition to primary procedure)
Q4438 Pretect, per square centimeter (add-on, list separately in addition to primary procedure)
Q4439 Instagraft, per square centimeter (add-on, list separately in addition to primary procedure)
Q4440 Curamatrix, per square centimeter (add-on, list separately in addition to primary procedure)
Q5161 Injection, denosumab-kyqq (aukelso/bosaya), biosimilar, 1 mg
Q5162 Injection, denosumab-nxxp (bildyos/bilprevda), biosimilar, 1 mg

Descriptions revised 7

CodeWas, and is now
A2014 Omeza collagen matrix, per 100 mg Omeza collagen matrix or omeza complete matrix, per 100 mg
A2037 G4derm plus, per milliliter G4derm plus/suprello, per milliliter
C7567 Bronchoscopy, rigid or flexible, including fluoroscopic guidance when performed, with transbronchial needle aspiration biopsy(s), trachea, main stem and/or lobar bronchus(i), with computer-assisted image-guided naviagation Bronchoscopy, rigid or flexible, including fluoroscopic guidance when performed, with transbronchial needle aspiration biopsy(s), trachea, main stem and/or lobar bronchus(i), with computer-assisted image-guided navigation
C9814 Continuous anesthesia echogenic conduction catheter set (e.g. sonolong), non-opioid medical device (must be a qualifying medicare non-opioid medical device for post-surgical pain relief in accordance with section 4135 of the caa, 2023) Continuous anesthesia echogenic conduction catheter set (e.g. sonolong, e-cath), including all components, non-opioid medical device (must be a qualifying medicare non-opioid medical device for post-surgical pain relief in accordance with section 4135 of the caa, 2023)
G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to home or residence or office/outpatient evaluation and management service, new or established)
J0174 Injection, lecanemab-irmb, 1 mg Lecanemab-irmb, for intravenous injection, 1 mg
L6028 Partial hand, finger, and thumb prosthesis without prosthetic digit(s)/thumb, amputation at metacarpal level, including flexible or non-flexible interface, molded to patient model, including palm, for use without external power and/or passive prosthetic digit/thumb, not including inserts described by l6692 Partial hand, finger, and thumb prosthesis without prosthetic digit(s) /thumb, amputation at metacarpal level, including flexible or non-flexible interface, molded to patient model, for use without external power and/or passive prosthetic digit/thumb, not including inserts described by l6692

Terminated 6

CodeDescription
C9145 Injection, aprepitant, (aponvie), 1 mg
C9307 Injection, linvoseltamab-gcpt, 1 mg
C9308 Injection, carboplatin (avyxa), 1 mg
L6000 Partial hand, thumb remaining
L6010 Partial hand, little and/or ring finger remaining
L6020 Partial hand, no finger remaining